OUR PIPELINEWe're pursuing every opportunity to develop and bring our investigational medicines* to patients.
Research Partnerships >
MULTIPLE IMMUNE & INFLAMMATORY TARGETS
Licensed or Partnered >
PULMONARY ARTERIAL HYPERTENSION
RARE CENTRAL NERVOUS SYSTEM TARGETS
Preclinical to Phase 1
*Arena is a clinical stage pharmaceutical company that does not have any medicines or products approved for use by any health authority.
**RIST4721 is being developed by Aristea Therapeutics, Inc. in collaboration with Arena. Arena has an exclusive option to acquire Aristea and the RIST4721 program.
If you have questions about an Expanded Access or Compassionate Use Program, please contact firstname.lastname@example.org